Bio-diagnostic performances of microRNAs set related to DNA damage response pathway among hepatitis C virus-associated hepatocellular carcinoma patients

Abstract Background Up to date, a well-defined microRNAs (miRNAs) profile involved in hepatocellular carcinoma (HCC) pathogenesis remains indecisive. Thus, employing miRNAs for HCC diagnosis is demanded for early therapeutic interventions. We aimed to evaluate the usage of miRNAs set related to the...

Full description

Bibliographic Details
Main Authors: Sara M. Abdo, Wafaa Gh. Shousha, Amal Ahmed Mohamed, Mohamed Elshobaky, Mohamed Saleh, Mostafa Mohamed Abdelhamid Ali
Format: Article
Language:English
Published: Elsevier 2023-08-01
Series:Journal of Genetic Engineering and Biotechnology
Subjects:
Online Access:https://doi.org/10.1186/s43141-023-00537-2
_version_ 1827267082632298496
author Sara M. Abdo
Wafaa Gh. Shousha
Amal Ahmed Mohamed
Mohamed Elshobaky
Mohamed Saleh
Mostafa Mohamed Abdelhamid Ali
author_facet Sara M. Abdo
Wafaa Gh. Shousha
Amal Ahmed Mohamed
Mohamed Elshobaky
Mohamed Saleh
Mostafa Mohamed Abdelhamid Ali
author_sort Sara M. Abdo
collection DOAJ
description Abstract Background Up to date, a well-defined microRNAs (miRNAs) profile involved in hepatocellular carcinoma (HCC) pathogenesis remains indecisive. Thus, employing miRNAs for HCC diagnosis is demanded for early therapeutic interventions. We aimed to evaluate the usage of miRNAs set related to the SuperPath: miRNAs involved in DNA damage response pathway as effective biomarkers for HCV-related HCC diagnosis. Results The study enrolled 97 patients with HCV-related HCC, 84 with hepatitis C virus (HCV), 97 with liver cirrhosis (LC), and 84 healthy individuals. Serum miRNA-23a, miRNA-203, miRNA-100-5p, and miRNA-16 were quantified using qRT-PCR experiments, AFP and routine LFTs were estimated via standard techniques. Pathway enrichment analysis along with the construction of miRNAs regulatory network were performed. With respect to healthy individuals, miRNA-203, miRNA-100-5p, and miRNA-16 were significantly downregulated in HCC, HCV, and LC groups, while miRNA-23a showed significant upregulation (p < 0.001). miRNAs exhibited significant correlations with AFP, ALT, AST, and albumin. Also, elevated levels of miRNA-23a were recognized in patients with multiple focal lesions and/or lesion size > 5 cm. Additionally, the diagnostic performance of miRNA-23a expression level at a selected cut-off value of 3.99 overtakes AFP, while expressions of miR-203, miRNA-100-5p, and miRNA-16 represent poor diagnostic outcomes. Conclusions Keeping in mind the individual variability and high level of heterogeneity in HCC, our data revealed the diagnostic value of miRNA-23a expression in HCV-related HCC patients. Further extra in silico HCC-specific microRNAs sets are demanded in diagnosis.
first_indexed 2024-03-12T14:16:27Z
format Article
id doaj.art-5b71d740d24a413b859b477d46612ab0
institution Directory Open Access Journal
issn 2090-5920
language English
last_indexed 2025-03-22T04:28:05Z
publishDate 2023-08-01
publisher Elsevier
record_format Article
series Journal of Genetic Engineering and Biotechnology
spelling doaj.art-5b71d740d24a413b859b477d46612ab02024-04-28T04:54:29ZengElsevierJournal of Genetic Engineering and Biotechnology2090-59202023-08-0121111110.1186/s43141-023-00537-2Bio-diagnostic performances of microRNAs set related to DNA damage response pathway among hepatitis C virus-associated hepatocellular carcinoma patientsSara M. Abdo0Wafaa Gh. Shousha1Amal Ahmed Mohamed2Mohamed Elshobaky3Mohamed Saleh4Mostafa Mohamed Abdelhamid Ali5Biochemistry Division, Chemistry Department, Faculty of Science, Helwan UniversityBiochemistry Division, Chemistry Department, Faculty of Science, Helwan UniversityBiochemistry Department, National Hepatology and Tropical Medicine Research Institute, Cairo UniversityInternal Medicine Department, Faculty of Medicine, Cairo UniversityInternal Medicine department, National Hepatology and Tropical Medicine Research InstituteBiochemistry Division, Chemistry Department, Faculty of Science, Helwan UniversityAbstract Background Up to date, a well-defined microRNAs (miRNAs) profile involved in hepatocellular carcinoma (HCC) pathogenesis remains indecisive. Thus, employing miRNAs for HCC diagnosis is demanded for early therapeutic interventions. We aimed to evaluate the usage of miRNAs set related to the SuperPath: miRNAs involved in DNA damage response pathway as effective biomarkers for HCV-related HCC diagnosis. Results The study enrolled 97 patients with HCV-related HCC, 84 with hepatitis C virus (HCV), 97 with liver cirrhosis (LC), and 84 healthy individuals. Serum miRNA-23a, miRNA-203, miRNA-100-5p, and miRNA-16 were quantified using qRT-PCR experiments, AFP and routine LFTs were estimated via standard techniques. Pathway enrichment analysis along with the construction of miRNAs regulatory network were performed. With respect to healthy individuals, miRNA-203, miRNA-100-5p, and miRNA-16 were significantly downregulated in HCC, HCV, and LC groups, while miRNA-23a showed significant upregulation (p < 0.001). miRNAs exhibited significant correlations with AFP, ALT, AST, and albumin. Also, elevated levels of miRNA-23a were recognized in patients with multiple focal lesions and/or lesion size > 5 cm. Additionally, the diagnostic performance of miRNA-23a expression level at a selected cut-off value of 3.99 overtakes AFP, while expressions of miR-203, miRNA-100-5p, and miRNA-16 represent poor diagnostic outcomes. Conclusions Keeping in mind the individual variability and high level of heterogeneity in HCC, our data revealed the diagnostic value of miRNA-23a expression in HCV-related HCC patients. Further extra in silico HCC-specific microRNAs sets are demanded in diagnosis.https://doi.org/10.1186/s43141-023-00537-2HCC,HCV-related HCCmiRNA-23amiRNA-203miRNA-100-5pmiRNA-16AFP
spellingShingle Sara M. Abdo
Wafaa Gh. Shousha
Amal Ahmed Mohamed
Mohamed Elshobaky
Mohamed Saleh
Mostafa Mohamed Abdelhamid Ali
Bio-diagnostic performances of microRNAs set related to DNA damage response pathway among hepatitis C virus-associated hepatocellular carcinoma patients
Journal of Genetic Engineering and Biotechnology
HCC,HCV-related HCC
miRNA-23a
miRNA-203
miRNA-100-5p
miRNA-16
AFP
title Bio-diagnostic performances of microRNAs set related to DNA damage response pathway among hepatitis C virus-associated hepatocellular carcinoma patients
title_full Bio-diagnostic performances of microRNAs set related to DNA damage response pathway among hepatitis C virus-associated hepatocellular carcinoma patients
title_fullStr Bio-diagnostic performances of microRNAs set related to DNA damage response pathway among hepatitis C virus-associated hepatocellular carcinoma patients
title_full_unstemmed Bio-diagnostic performances of microRNAs set related to DNA damage response pathway among hepatitis C virus-associated hepatocellular carcinoma patients
title_short Bio-diagnostic performances of microRNAs set related to DNA damage response pathway among hepatitis C virus-associated hepatocellular carcinoma patients
title_sort bio diagnostic performances of micrornas set related to dna damage response pathway among hepatitis c virus associated hepatocellular carcinoma patients
topic HCC,HCV-related HCC
miRNA-23a
miRNA-203
miRNA-100-5p
miRNA-16
AFP
url https://doi.org/10.1186/s43141-023-00537-2
work_keys_str_mv AT saramabdo biodiagnosticperformancesofmicrornassetrelatedtodnadamageresponsepathwayamonghepatitiscvirusassociatedhepatocellularcarcinomapatients
AT wafaaghshousha biodiagnosticperformancesofmicrornassetrelatedtodnadamageresponsepathwayamonghepatitiscvirusassociatedhepatocellularcarcinomapatients
AT amalahmedmohamed biodiagnosticperformancesofmicrornassetrelatedtodnadamageresponsepathwayamonghepatitiscvirusassociatedhepatocellularcarcinomapatients
AT mohamedelshobaky biodiagnosticperformancesofmicrornassetrelatedtodnadamageresponsepathwayamonghepatitiscvirusassociatedhepatocellularcarcinomapatients
AT mohamedsaleh biodiagnosticperformancesofmicrornassetrelatedtodnadamageresponsepathwayamonghepatitiscvirusassociatedhepatocellularcarcinomapatients
AT mostafamohamedabdelhamidali biodiagnosticperformancesofmicrornassetrelatedtodnadamageresponsepathwayamonghepatitiscvirusassociatedhepatocellularcarcinomapatients